EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activin-A has dual roles in osteoclast formation and foreign body giant cell differentiation from human CD14+ monocytes

Elina Kylmäoja, Sami Kauppinen, Faleh Abushahba, Mikko Finnilä, Mikko Ritala, Petri Lehenkari, Juha Tuukkanen, Teun J de Vries, Ton Schoenmaker

Bone · 2026

DOI: 10.1016/j.bone.2026.117814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Elina Kylmäoja und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Translational Medicine, Department of Anatomy and Cell Biology, Medical Research Center, P.O. Box 5000, 90014, University of Oulu, O…. Hauptthemen laut MEDLINE: Osteoclasts, Cell Differentiation, Activins, Lipopolysaccharide Receptors. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Jane and Aatos Erkko Fundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoclasts and foreign body giant cells (FBGCs) are multinucleated cells derived from monocytes, but they have distinct functions. Osteoclasts resorb bone while FBGCs form in response to foreign material. Regarding bone implants, osteoclasts are responsible for implant integration, but also for bone resorption associated to implant loosening, while FBGCs play a role in the immune response to the foreign material. Little is known about which proteins in the local environment fine-tune the multinucleation of osteoclasts or FBGCs. One candidate is Activin A (ActA). It has been shown to induce larger, more active osteoclasts, but its effect on FBGC differentiation is unknown. We investigated the effect of ActA on the differentiation of osteoclasts and FBGCs from human CD14-positive monocytes. The number of multinucleated cells and the cell area was measured. qPCR was performed to assess the effect of ActA on gene expression. ActA's influence on osteoclast and FBGC formation was studied on plastic, bone and hydroxyapatite coated Titanium discs (ALD-HA). ActA induced fewer, but bigger and more active osteoclasts on plastic and bone. In contrast, ActA did not have an effect on FBGC number. On ALD-HA, ActA reduced the number of FBGCs, but did not influence osteoclast numbers. qPCR showed that ActA upregulated the expression of several genes such as TRAcP, CIITA, OLR1, RHOBTB1 and ALK4, but mainly in osteoclasts. These results show that ActA has a different effect on osteoclasts compared to FBGCs. This difference could be caused by a difference in the expression in the canonical ActA receptor ALK4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsCell DifferentiationActivinsLipopolysaccharide ReceptorsMonocytesGiant Cells, Foreign-BodyHumansGene Expression Regulation

Stichwörter der Autor:innen

Activin ABiomaterialsForeign body giant cellOsteoclast

Substanzen

activin AActivinsLipopolysaccharide ReceptorsCD14 protein, human

Autor:innen und Institutionen

  • Research Unit of Translational Medicine, Department of Anatomy and Cell Biology, Medical Research Center, P.O. Box 5000, 90014, University of Oulu, Oulu, Finland. Electronic address: elina.kylmaoja@oulu.fi.
  • Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland. Electronic address: sami.kauppinen@oulu.fi.
  • Department of Prosthetic Dentistry and Stomatognathic Physiology, Institute of Dentistry, University of Turku, Turku, Finland; Department of Biomaterials Science and Turku Clinical Biomaterials Center-TCBC, Institute of…
  • Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland. Electronic address: mikko.finnila@oulu.fi.
  • Department of Chemistry, University of Helsinki, P.O. Box 55, 00014, Helsinki, Finland.
  • Research Unit of Translational Medicine, Department of Anatomy and Cell Biology, Medical Research Center, P.O. Box 5000, 90014, University of Oulu, Oulu, Finland. Electronic address: petri.lehenkari@oulu.fi.

Förderung

  • Research Council of Finland
  • Jane and Aatos Erkko Fundation

Zitieren

APA

Kylmäoja, E., Kauppinen, S., Abushahba, F., Finnilä, M., Ritala, M., Lehenkari, P., Tuukkanen, J., de Vries, T. J., & Schoenmaker, T. (2026). Activin-A has dual roles in osteoclast formation and foreign body giant cell differentiation from human CD14+ monocytes. Bone. https://doi.org/10.1016/j.bone.2026.117814

Vancouver

Kylmäoja E, Kauppinen S, Abushahba F, Finnilä M, Ritala M, Lehenkari P, et al. Activin-A has dual roles in osteoclast formation and foreign body giant cell differentiation from human CD14+ monocytes. Bone. 2026. doi:10.1016/j.bone.2026.117814

BibTeX
@article{Kylmoja2026,
  author = {Kylmäoja, Elina and Kauppinen, Sami and Abushahba, Faleh and Finnilä, Mikko and Ritala, Mikko and Lehenkari, Petri and Tuukkanen, Juha and de Vries, Teun J and Schoenmaker, Ton},
  title = {Activin-A has dual roles in osteoclast formation and foreign body giant cell differentiation from human CD14+ monocytes},
  journal = {Bone},
  year = {2026},
  doi = {10.1016/j.bone.2026.117814}
}
Kostenlos starten →